Thermo Fisher Scientific To Acquire Olink, A Leader In Next-Generation Proteomics For $26.00 Per Common Share In Cash
Portfolio Pulse from Benzinga Newsdesk
Thermo Fisher Scientific Inc. (TMO) has announced plans to acquire Olink Holding AB (OLK) for $26.00 per common share in cash, a 74% premium to Olink's closing price on October 16, 2023. The deal values Olink at approximately $3.1 billion. Olink's proprietary technology, Proximity Extension Assay (PEA), provides high throughput protein analysis. The acquisition is expected to be completed by mid-2024, subject to regulatory approvals. Olink is expected to deliver over $200M of revenue in 2024 and grow mid-teens organically as part of Thermo Fisher.
October 17, 2023 | 12:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Olink's shareholders could benefit from the acquisition by Thermo Fisher, which offers a 74% premium to the closing price of Olink's shares on October 16, 2023.
The acquisition offer from Thermo Fisher represents a significant premium to Olink's recent share price, which could result in substantial gains for Olink's shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Thermo Fisher's acquisition of Olink could enhance its capabilities in the proteomics market and provide strong synergy opportunities.
The acquisition of Olink could provide Thermo Fisher with access to advanced proteomics discovery and development solutions, potentially enhancing its market position and creating synergy opportunities.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100